Drug Companies vs. Brazil: The threat to public health

Thumbnail
Name:
bp-drug-companies-vs-brazil-01 ...
Size:
152.2Kb
Format:
PDF
Description:
English paper
Download
Thumbnail
Name:
bp-drug-companies-vs-brazil-01 ...
Size:
171.9Kb
Format:
PDF
Description:
Portugese paper
Download
Thumbnail
Name:
bp-drug-companies-vs-brazil-01 ...
Size:
159.7Kb
Format:
PDF
Description:
Spanish paper
Download
Publication date
2001-05-01
Subject
Health
Keywords
HIV and AIDS
Access to medicines
Country
Brazil

Metadata
Show full item record
Publisher(s)
Oxfam International
Document type
Briefing paper
Description
The access of impoverished Brazilians to essential medicines, including those required for treatment of HIV/AIDS, is under threat. International pharmaceutical firms, with the backing of the United States government, are trying to ensure that Brazil has to buy the expensive patented drugs that they manufacture, rather than have access to the cheaper generic drugs that the country is making for itself or could buy from countries such as India. The companies are also resisting tighter price controls on their products. Oxfam believes that higher prices for medicines will cause unnecessary sickness and death among the sixty million Brazilians living in poverty, and calls on the US government and the companies to stop putting pressure on Brazil to change its policies.
Pages
17
ISBN
978-1-84814-323-4
URI
http://hdl.handle.net/10546/114469
Additional Links
https://policy-practice.oxfam.org.uk/publications/drug-companies-vs-brazil-the-threat-to-public-health-114469
Collections